Compare Humana Inc (HUM) vs Vanguard Tax Managed Fund FTSE Developed Markets ETF (VEA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Vanguard Tax Managed Fund FTSE Developed Markets ETF — how do they compare? Humana Inc trades at $433 (market cap $46.49B), while Vanguard Tax Managed Fund FTSE Developed Markets ETF trades at $70.34 (market cap $323.80B). The key difference: Vanguard Tax Managed Fund FTSE Developed Markets ETF is far larger — about 7× Humana Inc's market cap, and Humana Inc pays a 0.91% dividend while Vanguard Tax Managed Fund FTSE Developed Markets ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 51 Days and Vanguard Tax Managed Fund FTSE Developed Markets ETF for 131 Days on average.
| HUM | VEA | |
|---|---|---|
Market Cap | $46.49B | $323.80B |
Volume | 2,567,704 | 17,001,112 |
Sector | Health | — |
52-Week High | $409.85 | $73.79 |
52-Week Low | $163.67 | $58.90 |
Typical Hold Time | 51 Days | 131 Days |
Enterprise Value | $53.84B | — |
Dividend Yield | 0.91% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $431.03, up 8.71% over the past day, reflecting strong momentum following a Barclays upgrade and positive earnings beats. The stock exhibits a bullish technical trend, with support at $378 and resistance at $394. Revenue has grown steadily from $92.9B in 2022 to $129.7B in 2025, though net income margins have compressed to 0.88%. Analyst consensus is a Buy with a $457.05 price target, and recent news highlights corporate initiatives and institutional investments.
The outlook for HUM is cautiously optimistic, driven by revenue growth and analyst support, but risks include margin pressure and regulatory scrutiny. Investment opportunity lies in execution of Medicare Advantage strategies, while key risks involve competitive pressures and potential fiduciary concerns highlighted in recent shareholder notices.
VEA trades at $70.35 with minimal daily movement (+0.13%). Technical indicators show a bearish trend with strong sell signals from moving averages and oscillators, though RSI suggests potential oversold conditions. The ETF maintains competitive advantages with a low 0.03% expense ratio and higher dividend yield compared to peers. Recent institutional activity shows mixed sentiment with both significant position increases and reductions among major holders.
VEA offers cost-efficient exposure to developed international markets excluding the US, but faces headwinds from global market volatility. The bearish technical setup and mixed institutional positioning suggest cautious near-term outlook, though the fund's structural advantages provide long-term appeal for diversified international exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Vanguard Tax Managed Fund FTSE Developed Markets ETF
The fund employs an indexing investment approach designed to track the performance of the FTSE Developed All Cap ex US Index, a market-capitalization-weighted index that is made up of approximately 4022 common stocks of large-, mid-, and small-cap companies located in Canada and the major markets of Europe and the Pacific region. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VEA →
